Applied Therapeutics
APLT
APLT was delisted on the 2nd of February, 2026.
0 hedge funds and large institutions have $0 invested in Applied Therapeutics in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 51 closing their positions.
40.81% less ownership
Funds ownership: 40.81% → 0% (-41%)
100% less funds holding
Funds holding: 52 → 0 (-52)
100% less capital invested
Capital invested by funds: $5.93M → $0 (-$5.93M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 51
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$2.17M |
| 2 |
KCM
Knoll Capital Management
Miami,
Florida
|
-$605K |
| 3 |
DAM
Deltec Asset Management
New York
|
-$385K |
| 4 |
BlackRock
New York
|
-$325K |
| 5 |
Pathstone Holdings
Englewood,
New Jersey
|
-$305K |
APLT Hedge Fund Activity: Q1 2026 in Review
0 of the 8,146 institutional investors tracked by Wall St. Rank reported a position in Applied Therapeutics (APLT) for Q1 2026, worth a combined $0 — down 100% from $5.93M a quarter earlier.
Sellers outnumbered buyers: 51 funds closed out of APLT and 0 opened new positions — a net loss of 51 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was T. Rowe Price Investment Management, exiting entirely with an estimated $2.17M sold.
- 0 institutional investors held Applied Therapeutics (APLT) as of Q1 2026, down from 52 in Q4 2025.
- Funds reported $0 of Applied Therapeutics stock for Q1 2026, down 100% quarter-over-quarter.
- 0 funds opened new Applied Therapeutics positions in Q1 2026 and 51 closed out, a net change of -51 holders.
- The largest Applied Therapeutics seller in Q1 2026 was T. Rowe Price Investment Management, an estimated $2.17M sold.
Based on aggregated 13F filings for Q1 2026.